网站综合信息 www.bjcancer.net
    • 标题:
    • British Journal of Cancer 
    • 关键字:
    • nature nature publishing group BJC British Journal Cancer cancer r 
    • 描述:
    •  
    • 域名信息
    • 域名年龄:11年8个月17天  注册日期:2013年03月05日  到期时间:2020年03月05日
      邮箱:domainabuse  电话:+1.8887802723
      注册商:CSC Corporate Domains, Inc. 
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 百度
    • 1  
    • 14,900  
    • 快照:无首页快照  
    • Google
    • 0  
    • 0  
    • pr:7  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 0  
    •  
    • 评级:1/10  
    • 360搜索
    • 1  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • -  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • dmoz目录收录
    • -  
    • 流量走势图
    域名注册Whois信息

    bjcancer.net

    域名年龄: 11年8个月17天
    注册时间: 2013-03-05
    到期时间: 2020-03-05
    注 册 商: CSC Corporate Domains, Inc.
    注册邮箱: domainabuse
    联系电话: +1.8887802723

    获取时间: 2019年06月12日 11:48:13
    Domain Name: BJCANCER.NET
    Registry Domain ID: 1784348526_DOMAIN_NET-VRSN
    Registrar WHOIS Server: whois.corporatedomains.com
    Registrar URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
    Updated Date: 2019-03-01T06:41:32Z
    Creation Date: 2013-03-05T10:27:36Z
    Registry Expiry Date: 2020-03-05T10:27:36Z
    Registrar: CSC Corporate Domains, Inc.
    Registrar IANA ID: 299
    Registrar Abuse Contact Email: domainabuse
    Registrar Abuse Contact Phone: 8887802723
    Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
    Name Server: NS1.NETNAMES.NET
    Name Server: NS2.NETNAMES.NET
    Name Server: NS5.NETNAMES.NET
    Name Server: NS6.NETNAMES.NET
    DNSSEC: unsigned
    URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
    >>> Last update of whois database: 2019-06-12T03:48:00Z <<<

    For more information on Whois status codes, please visit https://icann.org/epp

    Domain Name: bjcancer.net
    Registry Domain ID: 1784348526_DOMAIN_NET-VRSN
    Registrar WHOIS Server: whois.corporatedomains.com
    Registrar URL: www.cscprotectsbrands.com
    Updated Date: 2019-03-01T06:41:32Z
    Creation Date: 2013-03-05T10:27:36Z
    Registrar Registration Expiration Date: 2020-03-05T10:27:36Z
    Registrar: CSC CORPORATE DOMAINS, INC.
    Sponsoring Registrar IANA ID: 299
    Registrar Abuse Contact Email: domainabuse
    Registrar Abuse Contact Phone: +1.8887802723
    Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
    Registry Registrant ID:
    Registrant Name: IS Admin
    Registrant Organization: Cancer Research UK
    Registrant Street: Angel Building
    Registrant City: London
    Registrant State/Province: London
    Registrant Postal Code: EC1V 4AD
    Registrant Country: GB
    Registrant Phone: +44.2072420200
    Registrant Phone Ext:
    Registrant Fax: +44.2070618011
    Registrant Fax Ext:
    Registrant Email: is_admin
    Registry Admin ID:
    Admin Name: Fiona Hutchison
    Admin Organization: Cancer Research UK
    Admin Street: Angel Building
    Admin City: London
    Admin State/Province: Greater London
    Admin Postal Code: EC1V 4AD
    Admin Country: GB
    Admin Phone: +44.2034695150
    Admin Phone Ext:
    Admin Fax: +44.2033573228
    Admin Fax Ext:
    Admin Email: fiona.hutchison
    Registry Tech ID:
    Tech Name: NetNames Hostmaster
    Tech Organization: Netnames Limited
    Tech Street: 3rd Floor Prospero House
    Tech City: London
    Tech State/Province: London
    Tech Postal Code: SE1 1GA
    Tech Country: GB
    Tech Phone: +44.2070159370
    Tech Phone Ext:
    Tech Fax: +44.2070159375
    Tech Fax Ext:
    Tech Email: hostmaster
    Name Server: dns1.cscdns.net
    Name Server: dns2.cscdns.net
    DNSSEC: unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
    >>> Last update of WHOIS database: 2019-03-01T06:41:32Z <<<

    For more information on Whois status codes, please visit https://icann.org/epp

    Corporation Service Company(c) (CSC) The Trusted Partner of More than 50% of the 100 Best Global Brands.

    Contact us to learn more about our enterprise solutions for Global Domain Name Registration and Management, Trademark Research and Watching, Brand, Logo and Auction Monitoring, as well SSL Certificate Services and DNS Hosting.

    NOTICE: You are not authorized to access or query our WHOIS database through the use of high-volume, automated, electronic processes or for the purpose or purposes of using the data in any manner that violates these terms of use. The Data in the CSC WHOIS database is provided by CSC for information purposes only, and to as
    其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2019年05月22日 03:42:16
    网址:http://www.bjcancer.net/
    标题:British Journal of Cancer
    关键字:nature, nature publishing group, BJC, British Journal Cancer, cancer research, cancers, prescription drugs, breast cance
    描述:
    主体:
    We use cookies to improve your experience with our site.Accept and close | More info.Jump to main contentJump to navigationnature.com homepagePublications A-Z indexBrowse by subjectMy accountSubmit manuscriptRegisterSubscribeLoginCartSearchAdvanced searchWelcome to BJCMultidisciplinary Journal of Cancer ResearchBJC publishes significant original papers and reviews that:increase understanding of the causes of cancerinform timely detection and accurate diagnosisinvestigate molecular pathways relevant to cancer therapycontribute to the discovery of novel therapieshelp develop personalised therapydrive improvements in the treatment and survival of patientsBJC is one of the most-cited general cancer journalsVol 115, No 12(December 2016)ISSN 0007-09202015 Impact Factor 5.569*28/213 Oncology*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)Web FocusHot MinireviewsSee what scientists world-wide are reading!  View the most popular minireviews published in BJC.SupplementPARP inhibitors in ovarian cancerGuest editors: Jonathan A LedermannVol 113, No S1 (December 2015) Comprehensively reviews molecular and clinical evidence underlying the evolution of poly (ADP-ribose) polymerase (PARP) inhibitors culminating in the recent licensing approval of the first oral PARP inhibitor, for BRCA-mutated high-grade serous ovarian cancer.Organized by AstraZeneca UKGuidelinesGuidelines for the use of cell lines in biomedical researchCell-line misidentification and contamination with microorganisms, such as mycoplasma, together with instability, both genetic and phenotypic, are among the problems that continue to affect cell culture. Many of these problems are avoidable with the necessary foresight, and these Guidelines have been prepared to provide those new to the field and others engaged in teaching and instruction with the information necessary to increase their awareness of the problems and to enable them to deal with them effectively. Click to view these GuidelinesReportThe benefits and harms of breast cancer screening: an independent reviewM G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson and M WilcoxBreast screening may save lives if aggressive cancers are detected early and treated effectively, but many screen-detected cancers would otherwise have been without symptoms during the patient’s lifetime, so does treating them cause more harm than good?  This independent review, published here in full for the first time, addresses the evidence and uses this to make recommendations.  The debate is taken up by four lively Editorials written by opinion leaders in the field of breast cancer treatment.Editorials by:P Hall and D EastonA L HarrisC O'Donoghue and L EssermanM BaumGuidelinesGuidelines for the Welfare of Animals in Cancer ResearchUpdated, enhanced, and providing practical advice on animal welfare specifically for today's cancer researchers, these guidelines define and encourage sharing of best practice in laboratory work. Already

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2024-11-14 10:01, Process in 0.0065 second.